Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.86 CAD | -0.17% | -2.33% | +12.91% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.91% | 432M | |
+18.88% | 80.5B | |
+14.11% | 9.15B | |
-14.14% | 4.9B | |
+43.39% | 4.49B | |
+18.90% | 4.44B | |
+7.93% | 2.19B | |
-28.40% | 2.13B | |
+15.93% | 2.1B | |
-43.17% | 1.78B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics Brief: Entering into Exclusive License Agreement with Supernus Pharmaceuticals for Qelbree (viloxazine) in Canada